DEF 14A

Company

International Stem Cell CORP

Filed

April 24, 2025

Period of Report

June 17, 2025

Accession Number

0000950170-25-058111

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →